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Clinical and genetic risk factors for newonset diabetes mellitus after
transplantation (NODAT) in major transplant centres in Malaysia
ABSTRACT
Background: New-onset diabetes after transplantation (NODAT) is associated with reduced
patient and graft survival. This study examined the clinical and selected genetic factors
associated with NODAT among renal-transplanted Malaysian patients. Methods: This study
included 168 non-diabetic patients (58% males, 69% of Chinese ethnicity) who received renal
transplantation between 1st January 1994 to 31st December 2014, and were followed up in two
major renal transplant centres in Malaysia. Fasting blood glucose levels were used to diagnose
NODAT in patients who received renal transplantation within 1 year. Two single nucleotide
polymorphisms (SNPs), namely; rs1494558 (interleukin-7 receptor, IL-7R) and rs2232365
(mannosebinding leptin-2, MBL2) were selected and genotyped using Sequenom MassArray
platform. Cox proportional hazard regression analyses were used to examine the risk of
developing NODAT according to the different demographics and clinical covariates, utilizing
four time-points (one-month, three-months, six-months, one-year) post-transplant. Results:
Seventeen per cent of patients (n = 29, 55% males, 69% Chinese) were found to have
developed NODAT within oneyear of renal transplantation based on their fasting blood glucose
levels. NODAT patients had renal transplantation at an older age compared to non-NODAT
(39.3 ± 13.4 vs 33.9 ± 11.8 years, p = 0.03). In multivariate analysis, renal-transplanted
patients who received a higher daily dose of cyclosporine (mg) were associated with increased
risk of NODAT (Hazard ratio (HR) =1.01 per mg increase in dose, 95% confidence interval (CI)
1.00–1.01, p = 0.002). Other demographic (gender, ethnicities, age at transplant) and clinical
factors (primary kidney disease, type of donor, place of transplant, type of calcineurin inhibitors,
duration of dialysis pre-transplant, BMI, creatinine levels, and daily doses of tacrolimus and
prednisolone) were not found to be significantly associated with risk of NODAT. GA genotype of
rs1494558 (HR = 3.15 95% CI 1.26, 7.86) and AG genotype of rs2232365 (HR = 2.57 95% CI
1.07, 6.18) were associated with increased risk of NODAT as compared to AA genotypes.
Conclusion: The daily dose of cyclosporine and SNPs of IL-7R (rs1494558) and MBL2
(rs2232365) genes are significantly associated with the development of NODAT in the
Malaysian renal transplant population.
